Get ready for EU CTR implementation with Cromos Pharma The application of the European Union (EU). Clinical Trial Regulation (Regulation (EU) No 536/2014) will bring about significant changes to the way clinical trials are conducted in the EU. In this article Cromos Pharma’s Head of Central European Operations, Zsolt Kocsis, considers some of the key changes ahead. The implementation of the European Union (EU) Clinical
Cromos Pharma making sure your clinical trial is feasible It is estimated that up to 80% of clinical studies fail to recruit sufficient numbers of participants. These failures waste valuable resources and time as well as delaying new treatments reaching patients. At Cromos Pharma we understand how important it is to conduct robust feasibility assessments of clinical trials to optimize the chances of success.
Cromos Pharma supporting clinical research to beat heart disease World Heart Day (Wednesday, 29 September) is a day to raise awareness about the importance of your heart and ways to keep your heart healthy – no matter what age you are. It is also a day to recognize the incredible achievements in clinical research that have helped develop innovative therapies and treatments to improve the lives of
